Portable PCR Systems Market Report

Laboratories inside as well as outside of the hospital face the issue of working in a restricted area while ensuring that the quality of work performed is not hampered by a lack of equipment space. For example, Tianlong Science and Technology has introduced the new Gentier Mini+ real-time PCR system, which is portable, rapid, and always online, for mobile or small laboratories or on-site testing. The new Gentier Mini+, designed for excellent performance and mobility, addresses the challenge of restricted space and fragmented samples in laboratories to make workflow easier, more precise and more efficient. Initial detection and continuous monitoring of the pathogen are critical components of disease prevention. Dismantling the centralisation framework and integrating transportable laboratories is a novel approach to provide diagnostic help in resource-constrained and distant places.

With the sudden outbreak of the COVID-19 pandemic across the world, the necessity for accurate diagnosis grew significantly in countries. The approach proved to be the most dependable source of clinical diagnosis. This resulted in an insatiable demand for items like as reagents, tests and equipment from all over the world. Diagnostic firms like Thermo Fisher Scientific and Qiagen, among others, had tremendous revenue increases. According to Thermo Fisher Scientific Inc., revenue increased 15% to US$ 44.92 Bn in 2022. As a result, an increase in the number of polymerase chain reaction tests performed, pandemic and epidemic outbreaks and multiple product releases are expected to boost the global market's value throughout the forecast period.

One of the key challenges impeding this industry's growth is a lack of awareness about the technology sector in low-income countries. Nonetheless, the expensive nature of the systems and a lack of proficient workers could impede the expansion of portable PCR systems. They also usually require expensive service contracts to keep them calibrated. Many lab managers are still stuck with the traditional PCR design since they haven't seen the more portable and agile solutions that are now available. Despite their convenience, polymer portable PCR systems often struggle with lower sensitivity and specificity compared to advanced laboratory models, impacting diagnostic accuracy. Additionally, these systems may encounter issues such as sample contamination, complex usage protocols, and scalability limitations. Navigating stringent and region-specific regulatory requirements further complicates market entry and adoption, increasing time and costs. The effectiveness of these systems can be reduced in regions with unreliable power infrastructure and suboptimal sample handling.The broad market adoption is restricted by their specialized use in field diagnostics. Additionally, the management and interpretation of extensive data generated by these systems can hinder their integration into established workflows.

Major industry leaders utilize strategies that focus on launching new products, merging with competitors, and purchasing companies to grow their customer base and enhance their range of products. In July 2024, the Bio-Rad Laboratories has made significant steps in enhancing its market presence in the polymer portable PCR systems sector. The company's advancements in Droplet Digital PCR (ddPCR) technology include strategic partnerships with top oncology institutions and health networks to improve cancer patient monitoring. Additionally, Bio-Rad has broadened its product offerings to support the growing demand for Droplet Digital PCR in biopharma and translational research. These initiatives underscore Bio-Rad's commitment to advancing science and healthcare through cutting-edge diagnostic solutions.

Furthermore, In March 2023, Thermo Fisher Scientific unveiled its latest advancement in digital PCR technology the Applied Biosystems, QuantStudio, Absolute Q, AutoRun dPCR Suite. This innovative solution integrates the QuantStudio Absolute Q dPCR system with the Thermo Scientific Spinnaker Microplate Robot, offering extraordinary lab automation and high-throughput analysis. The suite supports up to 72 hours of hands-free operation, significantly enhancing productivity and efficiency for BioPharma and molecular research. With capabilities for multiplex analysis and large batch processing, it accelerates drug development and molecular research while minimizing manual intervention.

North America is expected to continue to dominate the global portable PCR system market. This expansion is attributed to the adoption of novel biotechnologies, increased awareness of PCR products, significant research funding allocation in national budgets, early availability of cutting-edge technologies and an increase in R&D activities in the region. For instance, the American Cancer Society estimates that 1.9 million new cancer cases diagnosed and 609,360 deaths due to cancer in the United States in 2022.  Furthermore, according to data updated by the CDC in April 2023, the CDC estimates that there have been at least 26 million illnesses, 290,000 hospitalisations and 19,000 flu deaths so far this season. As a result, the increased frequency of such diseases will likely encourage portable PCR systems use, boosting market growth throughout the forecast period.